CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer
Go back to CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer| (NASDAQ: CRVO) | Delayed: 2.62 +0.05 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.57 | 52 Week High | $ | |||
| Open | $2.55 | 52 Week Low | $ | |||
| Day High | $2.64 | P/E | N/A | |||
| Day Low | $2.55 | EPS | $ | |||
| Volume | 101,558 | |||||

